Chapter Four Inflammation - PowerPoint PPT Presentation

1 / 86
About This Presentation
Title:

Chapter Four Inflammation

Description:

Chapter Four Inflammation Su Min Definition: Inflammation is the protect response of living tissue which developed blood system to injury. – PowerPoint PPT presentation

Number of Views:245
Avg rating:3.0/5.0
Slides: 87
Provided by: kh0410
Category:

less

Transcript and Presenter's Notes

Title: Chapter Four Inflammation


1
Chapter FourInflammation
  • Su Min (??)

2
  • Definition
  • Inflammation is the protect response of living
    tissue which developed blood system to injury.
  • It involves- vascular, neuralgic, humoral and
    cellular response at the site of injury.

3
Section 1 Causes manifestion of Inflammation
4
Causes
  • Physical agents trauma, extremes of heat or
    cold, radiant ray, etc.
  • Chemical agents
  • exogenous substances
  • endogenous substances

5
Causes
  • Microbiologic agents Viruses, bacteria, fungi,
    protozoa, etc.
  • Necrosis tissue
  • Immunological reactions

6
Manifestion
  • 1. Local signs
  • (1) Redness
  • (2) Swelling
  • (3) Heat
  • (4) Pain
  • (5) Loss of function

7
(No Transcript)
8
Manifestion
  • 2. General responses
  • (1) Fever
  • (2) Leukocytosis
  • (3) Proliferation of the mononuclear phagocyte
    system
  • (4) Injury of parenchyma organs.

9
Section 2 Basic Pathologic Changes
10
  • The basic pathologic changes of inflammation in
    the site of injury are alteration, exudation, and
    proliferation.
  • 1. Alteration
  • (1) Definition The tissues or cells in the
    inflammatory site become degeneration and/or
    necrosis.

11
  • (2) Causes and mechanism
  • Be damaged by inflammatory factors directly.
  • Local blood circulation disturbance
  • Be affected by inflammatory mediators.
  • (3) Morphology
  • Parenchyma cells edema, fatty change, necrosis
    etc.
  • Interstitium edema, mucoid degeneration,
    fibrinoid degeneration, necrosis, etc.

12
  • 2. Vascular changes
  • (hyperemia and exudation)
  • (1) Changes in vascular flow and caliber
  • ? Changes in caliber
  • Transient arteriolar constriction
  • Persistent vasodilatation

13
  • ? Changes in flow
  • a. Initially rapid as a result of vasodilatation
    (active hyperemia)
  • b. Slowing and disturbance of axial flow as a
    result of increased blood viscosity secondary to
    loss of plasma into the tissue (congestion and
    edema)

14

15
  • ? Changes in the endothelium
  • Increased vascular permeability leading to the
    escape of a protein-rich fluid (exudates) into
    the interstitium.
  • a. Endothelial cell contraction, or increased
    transcytosis across the endothelial cytoplasm.
  • b. Direct endothelial injury, resulting in
    endothelial cell necrosis and detachment
  • c. Leakage from regenerating capillaries

16
  • (2) Fluid exudate
  • Normally the walls of small blood vessels are
    freely permeable to water and crystalloids but
    relatively impermeable to plasma proteins. The
    formation of protein-rich fluid exudates is
    facilitated by separation of the intercellular
    junction of the endothelium.

17
  • The fluid exude carries into the inflamed area
    the following important constituents
  • ? Serum bactericidal factors
  • a. Antibodies which act by opsonising bacteria
    prior to phagocytosis and by neutralizing
    exotoxins
  • b. Components of the complement system

18
  • ? Interferon a non-specific antiviral agent
  • ? Fibrinogen which is converted to fibrin. Fibrin
    is important in providing
  • a. Cement substance uniting severed tissues
  • b. Scaffold for repair processes
  • c. Barrier to the spread of organisms
  • d. Surface against which phagocytosis of
    adherent organisms is enhanced
  • ? Therapeutic agents-antibiotics,
    anti-inflammatory drugs, etc.

19
  • (3) Leukocyte exudates and phagocytosis
  • ? Leukocytic margination,rolling
  • ? Adhesionby the binding of adhesion
  • molectures (selectins, immunoglobulins,
  • intergrins, mucin-like glycoproteins)

20
  • ? Emigrating
  • It refers to the process by which motile white
    cells migrate out of blood vessels.
  • Although all leukocytes are more or less
    motile, the most active are the neutrophils and
    monocytes the most sluggish are the lymphocytes.
  • While cell emigration is an active,
    energy-dependent process.
  • Red blood cell out of blood vessels, called
    diapedesis, is believed to be passive loss of red
    blood cells through the points of rupture
    (blooding).

21
White cell transmigration
  • It is include following handings
  • ?WBC margination
  • ?
  • ?WBC adhesion with endothelial surface adhesion
    molecule
  • ?
  • ?WBC transmigration
  • 2-12 minute

22
  • ? Chemotaxis
  • Following extravasations, leukocytes emigrate
    in tissues toward the site of injury by a process
    called chemotaxis.
  • Exogenous chemo attractants bacterial products,
    etc.
  • Endogenous chemo attractants components of the
    (LTB4), cytokines, etc.

23
  • ? Phagocytosis
  • Recognition and attachment of the particle to
    the surface of the phagocyte? engulfment? killing
    and degradation

24
(No Transcript)
25
  • Types of leukocyte (inflammatory cells)
  • Leukocytes are out of blood vessels that are
    known as inflammatory cells.
  • a. Neutrophils
  • Small phagocytic cell
  • The two types of granules in the cytoplasm
  • Azurophil granules and specific granules.
  • The first cells to appear in perivascular
    spaces are the neutrophils.
  • Commonly seen in early stage of inflammation,
    and acute inflammation, and purulent inflammation.

26
  • b. Macrophages
  • Tissue macrophages are derived from blood
    monocytes that emigrate from blood vessels under
    influence of chemotactic factors.
  • Commonly seen in later stage of inflammation,
    chronic inflammation, non-purulent inflammation,
    and viral, or protozoal, or fungal infections.
    And macrophages are also related to specific
    immune response.

27
  • dusty cell
    Langhans giant cell
  • foamy cell
  • Macrophages could epithelioid cell
  • Formation heart failure cell

  • Multinucleate giant-cells foreign-body giant
    cell

28
  • c. Eosinophilia
  • Commonly seen in hypersensitivity reaction and
    human parasitological infections.
  • d. Lymphocytes and plasma cells
  • Commonly seen in virus infection and chronic
    inflammation.
  • e. Basophilic and mast cell

29
MacrM
30
  • 3. Proliferation
  • Proliferate constitution
  • Endothelium, macrophages, and fibroblasts
    commonly seen in later stage of inflammation

31
  • Section 3
  • Inflammatory Mediator

32
  • 1. Definition
  • It is the chemical substances which cause or
    participate in inflammation
  • (1) Mediators originate either from plasma or
    cells
  • (2) Most mediators perform their biologic
    activity by initially binding to specific
    receptors on target cells.
  • (3) A chemical mediator can stimulate the release
    of mediators by target cells themselves.

33
  • (4) Mediator can on one or few target cell types,
    or have widespread targets, or may even have
    differing effects, depending on cell and tissue
    types.
  • (5) Once activated and released from the cell,
    most of these mediators are short-lived
  • (6) Most mediators have potential harmful
    effects.

34
2. Types of mediator
  • (1) Cell produce
  • serotonin
  • Arachidonic acid metabolic products
    LTB4?LTC4?LTD4?LTE4
  • Cell products O2-, H2O2, acid protease, neutral
    proteinase.
  • Cytokine IL-1ß, 2,3,4,6,7,10,12, IFN-?, TNF-a,
    CSF.
  • Platelet activating factor( PAF)
  • nitric oxide(NO)

35
2. Types of mediator
  • (2) body fluid produce
  • Kinin system
  • Complement system
  • Clotting system

36
2. Types of mediator Summary of mediators of
acute inflammation
Mediator Source Action Action Action
Mediator Source Vascular Leakage Chemotaxis Other
Histamine and serotonin Mast cells, platelets _  
Bradykinin Plasma substrate _ Pain
C3a Plasma protein via liver _ Opsonic fragment (C3b)
C5a Macrophages Leukocyte adhesion, activation
37
Mediator Source Action Action Action
Mediator Source Vascular Leakage Chemotaxis Other
Prostaglandins Mast cells from membrane phospholipids Potentiate other mediators _ Vasodilation, pain, fever
Leukotriene B4 Leukocytes _ Leukocyte adhesion, activation
Leukotriene C4, D4, E4 Leukocytes, mast cells _ Bronchoconstriction, vasoconstriction
Oxygen metabolites Leukocytes _ Endothelial damage, tissue damage
38
Mediator Source Action Action Action
Mediator Source Vascular Leakage Chemotaxis Other
PAF Leukocytes, mast cells Bronchoconstriction, leukocyte priming
IL-1 and TNF Macrophages, other _ Acute phase reactio- ns, endothelial act- evasion
Chemokines Leukocytes, others _ Leukocyte activation
Nitric oxide Macrophages, endothelium Vasodilation, cytotoxicity
39
Main mediators function
Function Types of mediator
Vasodilation Histamine, Bradykinin, Nitric oxide, Prostaglandins PGE2, PGD2,PGF2, PGI2
Vascular Leakage Histamine, Bradykinin, C3a, C5a, PAF, active oxygen metabolic products, Leukotrienes C4, D4, E4 Substance P
Chemotaxis C5a, LTB4, bacterial products, IL-8, TNF.
Fever IL-1, IL-6, TNF, PG.
Pain PGE2, Bradykinin
Tissue damage Neutrophil and macrophage lysosomal enzymes Oxygen metabolites, Nitric oxide
40
  • Section 4
  • Types of Inflammation

41
  • 1. Classification according to duration
  • (1) Super-acute inflammation
  • Hoursdays
  • (2) Acute inflammation
  • Daysone month
  • (3) Sub-acute inflammation
  • One monthmonths
  • (4) Chronic inflammation

42
  • 2. Classification according to pathologic changes
  • (1) Alterative inflammation
  • ? Alterative changes are the most obviously,
    exudative and proliferate changes are slighter.
  • ? Commonly seen in parenchyma organs
  • ? Causes virus, toxin, chemical poison, etc.
  • ? e. g fulminant hepatitis, type B epidemic
    encephalitis, poliomyelitis, caseous pneumonia,
    etc.

43
  • (2) Exudative inflammation
  • Excess of a particular component of the
    inflammatory exudates imparts distinctive
    features.
  • ? Serous inflammation
  • Watery, low protein content, derived from blood
    or aerosol lining cells.

44
??????(??)
45
(No Transcript)
46
  • Commonly seen in mucous membrane, serosa, lung,
    loose connective tissue, skin.
  • Examplesblister formation following
    burning, or scalding
  • 2 the pleural effusion associated with
    tuberculosis, common cold, etc.

47
  • ? Fibrinous inflammation
  • a. Much fibrin due to coagulation of large
    fibrinogen outpouring.
  • b. Causes Shigellosis
  • Streptococcus pneumonias
  • Corynebacterium diphtherias
  • Hg poison
  • Uremia

48
  • c. Commonly seen in
  • (i) Serosa
  • (ii) Mucous membrane Pseudo-membrane
  • (iii) Lung
  • d. Examples rheumatic pericarditis, dysentery,
    diphtheria, lobular pneumonia, etc.

49
Hairy heart
50

51
diphtheria
52
Bacillary dysentery
53
  • ? Suppurative inflammation
  • a.Definition Much exudates with lots of
    neutrophils and liquefied necrotic tissue (pus).
  • Pus composed of dead and dying neutrophils,
    liquefied tissue, pyogenic organisms.
  • b. Causes staphylococci, pneumococcus,
    gonococci, gram-negative rods, and some
    nonhemolytic streptococci.

54
  • c. Types
  • (i) Abscess a localised collection of pus in an
    organ or tissue.
  • Abscess could formation
  • Ulcer localized defect in an epithelial surface
    due to necrosis.
  • Sinus a abnormal tract leading from a cavity to
    the surface.
  • Fistula a tract open at both ends, through which
    abnormal communication between two surface is
    established.

55
(No Transcript)
56
multi-abscess of kidney
57
abscess
58
(No Transcript)
59
fistula
abscess
sinus
60
(No Transcript)
61
  • (ii) Phlegmonous inflammation
  • Definition wide-spread purulent inflammation in
    loose tissue, and appendix
  • Causes hemolytic streptococci

62
(No Transcript)
63
  • (iii) Surface purulent inflammation and Empyema
  • Surface purulent inflammation
  • purulent inflammation of mucosal or serosa
    surface.
  • Empyema
  • a collection of pus in a hollow viscus, e. g.
    in the gall-bladder or appendix.

64
  • ? Haemorrhage inflammation
  • Inflammation associated with conspicuous
    haemorrhage as a result of vascular damage, e. g.
    meningococcus.
  • ? Catarrhal inflammation
  • Inflammation of mucosal surfaces with
    hypersecretion of mucus, e. g. common cold

65
  • (3) Proliferative inflammation
  • ? General proliferative inflammation
  • Proliferative constitutions
  • Fibroblasts, endothelium, macrophage, and
    sometimes coated-epithelium, adenocytes,
    parenchyma cells, etc. commonly seen in chronic
    inflammation

66
  • ? Special types
  • a. Inflammatory granuloma (granulomatous
    inflammation)
  • Definition Nodular area of histocytes
    (macrophages)
  • Proliferation that have been transformed into
    epithelioid cells, surrounded by a collar of
    lymphocytes, occasionally fibroblasts and plasma
    cells.

67
  • Types
  • (i) Infective granuloma
  • Tuberculosis, syphilis, sarcoidosis,
    cat-scratch fever, leprosy, brucellosis, some of
    the mycotic infections, etc.
  • Example granuloma of tuberculosis Focal
    aggregation of monocyter that have undergone
    alteration to epithelioid cells. These is caseous
    necrosis in the center. The enclosing wall
    contains several large multinucleate giant cells
    to the Longhand type, with peripheral orientation
    of the nuclei. And also lots of lymphocytes and
    some of fibroblasts.

68
(No Transcript)
69
Tuberculous granuloma, tubercle
70
Langhans giant cell
71
  • (ii) Foreign bodys granuloma
  • Features foreign bodies
  • Foreign body giant cell seen in association
    with particulate insoluble material. Nuclei
    scattered throughout cytoplasm. No caseous
    necrosis

72
Foreign body giant cell of brain
73
  • b. Inflammatory polyp

74
Nasal polyp
75
c. Inflammatory pseudo-tumor
76
Inflammatory pseudo-tumor
77
  • Sections 5
  • Course outcome of Inflammation

78
Course
  • (1) Acute inflammation
  • (2) Chronic inflammation

79
Outcomes
  • (1) Healing
  • (2) Delay and Persistence
  • (3) Spread
  • ?Direct
  • ? Lymphatic
  • Lymphangitis progressing to acute
    lymphadenitis.

80
  • ? Blood vessels
  • Bacteria Organisms? blood
  • Toxemia Toxin? blood
  • Septicemia ??
  • Multiplication of organisms in the blood
    stream.
  • Pyaemia, spread of pyogenic organisms in infected
    micro-thrombi via the blood-stream possibly
    giving rise to metastatic abscesses.

81
  • (4) Death resulting from
  • Toxaemia Bacteria e. g. endotoxic shock and
    its complications.
  • Involvement of vital organs, e. g. encephalitis,
    myocarditis.

82
  • Sections 6
  • Significances of Inflammation

83
1. Significances
  • (1) Inflammation is fundamentally a protective
    response whose ultimate goal is torid the
    organism of both the initial cause of cell injury
    and the consequences of such injury, the necrotic
    cells and tissues.
  • (2) Inflammatory response is closely
    intertwined with the process of repair.

84
  • (3) The inflammatory response occurs in the
    vascularized connective tissue.
  • (4) Inflammatory response of both vascular and
    cellular responses are mediated by inflammatory
    mediators chemical factors derived from plasma or
    cells and triggered by the inflammatory stimulus.
  • (5) However, inflammatory responses are not
    perfect that may be potentially harmful.

85
2. Aspects of inflammation
  • (1) Many systemic and local host factors
    influence the adequacy of the inflammatory-
    reparative response.
  • ? Nutrion condition
  • ? Immune condition
  • ? Endocrine condition
  • ? Characteristics of inflammatory organ or
    tissue

86
  • (2) The aspects of inflammatory factors
  • ? Character
  • ? Quantity
  • ? Duration of injury
Write a Comment
User Comments (0)
About PowerShow.com